uaetodaynews.com — Existing Drugs Combine To Fight World’s Most Common Liver Disease

Drug repurposing offers a promising and cost-effective strategy for developing new treatments. Metabolic dysfunction-associated steatotic liver disease is now recognized as the most widespread liver disorder globally, affecting roughly one in three adults. The condition develops when fat builds up inside liver cells, which can lead to serious liver damage and is strongly linked to (…)

Disclaimer: This news article has been republished exactly as it appeared on its original source, without any modification. We do not take any responsibility for its content, which remains solely the responsibility of the original publisher.

Author: University of Barcelona
Published on: 2025-10-07 07:41:00
Source: scitechdaily.com